US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Cresa Boston
Cresa Named Commercial Brokerage Firm of the Year by Boston Real Estate Times
September 25, 2026
From
Cresa Boston
Via
ACCESS Newswire
Cresa Boston Welcomes RJ Panzo of T3, Strengthening Life Sciences Practice
July 12, 2022
From
Cresa Boston
Via
AccessWire
Cresa Boston Welcomes Mitch Perez, Julia Ryan
March 24, 2022
From
Cresa Boston
Via
AccessWire
Cresa Publishes Insights & Predictions for 2022 Greater Boston Real Estate Market
February 16, 2022
From
Cresa Boston
Via
AccessWire
Cresa Boston Partners with Generation Bio to Find New RES Manufacturing Facility
September 14, 2021
From
Cresa Boston
Via
AccessWire
Cresa Boston Assists Vor Biopharma to Expand Its Footprint and Create In-house Clinical Manufacturing Facility
August 24, 2021
From
Cresa Boston
Via
AccessWire
Cresa Boston and Newmark Negotiate New Lease for Olink Proteomics at STONY BROOK
August 11, 2021
From
Cresa Boston
Via
AccessWire
Cresa Manages Corporate Relocation for Global Life Sciences Company Abcam
July 13, 2021
From
Cresa Boston
Via
AccessWire
Cresa Honored with Boston Business Journal’s Best Places to Work Award
June 18, 2021
From
Cresa Boston
Via
AccessWire
